Johannsen B, Syhre R, Spies H, Münze R
J Nucl Med. 1978 Jul;19(7):816-24.
The labeling of cysteine and its derivatives (penicillamine, N-acetylcysteine, cysteine ethyl ester) with 99Tc (99mTc) was studied as a model for the radiopharmaceutical preparation of Tc-99m mercaptide complexes. After the use of TcO4-, TcOCl52-, and TcBr62- as labeling agents for the Tc oxidation states VII, V, and IV, respectively, complexes of Tc(V) and Tc(IV) were prepared and characterized. The biologic behavior of these complexes was studied in rats. The substitutions in cysteine are responsible for substantial changes of net charge and lipophilicity in the Tc complexes, and the consequences on the excretion patterns in Wistar rats are discussed.
作为99Tc(99mTc)巯基络合物放射性药物制备的模型,研究了用99Tc(99mTc)标记半胱氨酸及其衍生物(青霉胺、N - 乙酰半胱氨酸、半胱氨酸乙酯)的情况。分别使用高锝酸盐(TcO4-)、五氯氧锝(TcOCl52-)和六溴锝(TcBr62-)作为锝氧化态VII、V和IV的标记剂后,制备并表征了Tc(V)和Tc(IV)络合物。在大鼠中研究了这些络合物的生物学行为。半胱氨酸中的取代作用导致锝络合物净电荷和亲脂性发生显著变化,并讨论了其对Wistar大鼠排泄模式的影响。